Delivery Order SPE2DB24D2205-SPE2DB24FDTFC
Award Date 4/25/24
Potential Completion Date 4/26/24
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,084.73 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564288461 HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $10,770.89 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a $3,694.32 Firm Fixed Price Delivery Order contract to supply HUMIRA(CF) PEN 40 MG/0.4 MLS. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies for military treatment...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a Firm Fixed Price delivery order contract valued at $7,366.52 for the supply of HUMIRA PEN 40MG.4ML 2S. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA and Amerisourcebergen, valued up to $999,999,999.00, for the provision of a comprehensive range of pharmaceutical products and medical supplies to support the Department...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,694.32 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $14,956.41 to AmerisourceBergen Drug Corp, a subsidiary of the for-profit parent company AmerisourceBergen Corporation. The contract is for the supply of HUMIRA (CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $2,770.74 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,199.08 Firm Fixed Price delivery order to Amerisourcebergen Drug Corp. The order, which has an ultimate completion date of October 15, 2024, is for 4566086883 - HUMIRA PEN 40 MG/0.8 MLS. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceuticals. This $1,596.02 award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 between DLA and Amerisourcebergen Drug Corp, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of medications and medical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $5,541.48 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA(CF) PEN 40 MG/0.4 MLS. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB24FDTFCDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract valued at $13,901.54 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.
Generated 7/25/24, 9:07 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.9k | 4/25/24 |